{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:40:59Z","timestamp":1760121659836,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ahj.2008.03.021","type":"journal-article","created":{"date-parts":[[2008,6,7]],"date-time":"2008-06-07T04:14:34Z","timestamp":1212812074000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Rationale and design of the Post-MI FREEE trial: A randomized evaluation of first-dollar drug coverage for post\u2013myocardial infarction secondary preventive therapies"],"prefix":"10.1016","volume":"156","clinical-trial-number":[{"clinical-trial-number":"nct00566774","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Niteesh K.","family":"Choudhry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troyen","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Spettell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan M.","family":"Brookhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blake","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliott M.","family":"Antman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Avorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Shrank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2008.03.021_bib1","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1161\/hc4601.099487","article-title":"Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization","volume":"104","author":"Yusuf","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.03.021_bib2","first-page":"e25","article-title":"Heart disease and stroke statistics\u20142008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.03.021_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"Br Med"},{"key":"10.1016\/j.ahj.2008.03.021_bib4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2008.03.021_bib5","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ehj.2004.06.003","article-title":"Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology","volume":"25","author":"Lopez-Sendon","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2008.03.021_bib6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ehj.2004.06.002","article-title":"Expert consensus document on beta-adrenergic receptor blockers","volume":"25","author":"Lopez-Sendon","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2008.03.021_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM199207233270406","article-title":"Cumulative meta-analysis of therapeutic trials for myocardial infarction","volume":"327","author":"Lau","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.03.021_bib8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.03.021_bib9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.107.188209","volume":"117","author":"Antman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.03.021_bib10","first-page":"e148","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.03.021_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.CIR.104.1.19","article-title":"Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota Heart Survey","volume":"104","author":"McGovern","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2008.03.021_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(02)02670-0","article-title":"The underutilization of cardiac medications of proven benefit, 1990 to 2002","volume":"41","author":"Stafford","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2008.03.021_bib13","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/archinte.166.7.806","article-title":"Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge","volume":"166","author":"Tricoci","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2008.03.021_bib14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.03.021_bib15","unstructured":"Ramsay SE. Personal communication. In; 2006."},{"key":"10.1016\/j.ahj.2008.03.021_bib16","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/archinte.166.17.1842","article-title":"Impact of medication therapy discontinuation on mortality after myocardial infarction","volume":"166","author":"Ho","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2008.03.021_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction","volume":"297","author":"Rasmussen","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2008.03.021_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2008.03.021_bib19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/01.mlr.0000178216.23514.b7","article-title":"Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much?","volume":"43","author":"Roblin","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.ahj.2008.03.021_bib20","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1001\/jama.291.19.2344","article-title":"Pharmacy benefits and the use of drugs by the chronically ill","volume":"291","author":"Goldman","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ahj.2008.03.021_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archinte.166.3.332","article-title":"The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions","volume":"166","author":"Shrank","year":"2006","journal-title":"Arch Intern Med"},{"author":"Lester","key":"10.1016\/j.ahj.2008.03.021_bib22"},{"key":"10.1016\/j.ahj.2008.03.021_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1377\/hlthaff.23.4.213","article-title":"Do drug benefits help Medicare beneficiaries afford prescribed drugs?","volume":"23","author":"Rector","year":"2004","journal-title":"Health Aff"},{"key":"10.1016\/j.ahj.2008.03.021_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.mlr.0000108742.26446.17","article-title":"Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care","volume":"42","author":"Piette","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.ahj.2008.03.021_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.298.1.61","article-title":"Prescription drug cost sharing: associations with medication and medical utilization and spending and health","volume":"298","author":"Goldman","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ahj.2008.03.021_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1377\/hlthaff.20.1.276","article-title":"Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter?","volume":"20","author":"Adams","year":"2001","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ahj.2008.03.021_bib27","first-page":"861","article-title":"A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost","volume":"7","author":"Fendrick","year":"2001","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ahj.2008.03.021_bib28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1377\/hlthaff.26.1.186","article-title":"Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis","volume":"26","author":"Choudhry","year":"2007","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ahj.2008.03.021_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.107.735605","article-title":"Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries","author":"Choudhry","year":"2008","journal-title":"Circulation"},{"issue":"5 Pt 1","key":"10.1016\/j.ahj.2008.03.021_bib30","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1475-6773.2005.00432.x","article-title":"Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending","volume":"40","author":"Briesacher","year":"2005","journal-title":"Health Serv Res"},{"issue":"5 Suppl","key":"10.1016\/j.ahj.2008.03.021_bib31","first-page":"S170","article-title":"Reducing patient drug acquisition costs can lower diabetes health claims","volume":"11","author":"Mahoney","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ahj.2008.03.021_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1377\/hlthaff.27.1.103","article-title":"Impact of decreasing copayments on medication adherence within a disease management environment","volume":"27","author":"Chernew","year":"2008","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ahj.2008.03.021_bib33","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0277-9536(85)90161-3","article-title":"The demand for prescription drugs as a function of cost-sharing","volume":"21","author":"Leibowitz","year":"1985","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ahj.2008.03.021_bib34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1525-1497.1999.10198.x","article-title":"Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database","volume":"14","author":"Petersen","year":"1999","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ahj.2008.03.021_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1067\/mhj.2002.123839","article-title":"A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario","volume":"144","author":"Austin","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2008.03.021_bib36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","article-title":"Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors","volume":"43","author":"Birman-Deych","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.ahj.2008.03.021_bib37","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the proportional hazards model","volume":"84","author":"Lin","year":"1989","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ahj.2008.03.021_bib38","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/hec.1041","article-title":"Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, Canada","volume":"14","author":"Contoyannis","year":"2005","journal-title":"Health Econ"},{"key":"10.1016\/j.ahj.2008.03.021_bib39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1259\/0007-1285-44-526-793","article-title":"Repeated assessment of results in clinical trials of cancer treatment","volume":"44","author":"Haybittle","year":"1971","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ahj.2008.03.021_bib40","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/bjc.1976.220","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design","volume":"34","author":"Peto","year":"1976","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ahj.2008.03.021_bib41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archinte.167.6.540","article-title":"Interventions to enhance medication adherence in chronic medical conditions: a systematic review","volume":"167","author":"Kripalani","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2008.03.021_bib42","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","article-title":"Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry","volume":"113","author":"Spertus","year":"2006","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308002317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308002317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:35:22Z","timestamp":1757568922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870308002317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0002870308002317"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2008.03.021","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of the Post-MI FREEE trial: A randomized evaluation of first-dollar drug coverage for post\u2013myocardial infarction secondary preventive therapies","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2008.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}